← Eichor
Study identifier: NCT06439901 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Optimizing Bronchopulmonary Cancer Screening

Condition: Bronchopulmonary Disease · Diagnoses Disease  ·  Sponsor: Institut Curie

PhaseNA
Planned participants500
Who can joinAll sexes, 50 Years to 74 Years
Healthy volunteersNo

About this study

The aim of this study is to evaluate the feasibility of performing a first screening for bronchopulmonary cancer by thoracic scanner in a French cohort within a dedicated, effective and structured network in the pilot centers participating in the study.

This description comes directly from the study's public registry record.

Talk to the study team

Catherine DANIEL, MD  ·  +33 1 44 32 40 00  ·  catherine.daniel@curie.fr

Nicolas GiRARD, PhD  ·  +33 1 44 32 40 00  ·  nicolas.girard@curie.fr

Always discuss trial participation with your own doctor first.

Locations (8)

Centre CTPS Bobigny BondyBobigny, FranceNot Yet Recruiting
Centre Municipal de Santé Simone VeilIssy-les-Moulineaux, FranceRecruiting
Centre Municipal de Santé Jacqueline Akoun-CornetMalakoff, FranceNot Yet Recruiting
Centre Municipal de Santé Maurice TénineMalakoff, FranceRecruiting
Centre de Santé Square de la MutualitéParis, FranceRecruiting
Institut CurieParis, FranceNot Yet Recruiting
Institut Mutualiste MontsourisParis, FranceNot Yet Recruiting
Centre de Santé MGENParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06439901